STOCK MARKET BSE NSE

Indigenous Anticoagulation BPV in Stage III Clinical Trial

India would be second country after USA to indigenously develop the  anticoagulation Bioprosthetic valve (BPV) for heart.

Published: 21st April 2016 08:34 PM  |   Last Updated: 21st April 2016 08:34 PM   |  A+A-

PUDUCHERRY: India would be second country after USA to indigenously develop the  anticoagulation Bioprosthetic valve (BPV) for heart, if the  clinical trials are successfully completed  giving hope to millions of people in the country to get a heart valve at half the cost, said  renowned Cardio thorasic surgeon Dr K M Cherian  of Frontier Life Line  and Dr K M Cherian Heart Foundation , Chennai.

The BPV  is being developed at the  basis medical institute of research Dr. K. M. Cherian Heart Foundation & the Frontier Lifeline near the Andhra Pradesh –Tamilnadu border  and is in stage III of Clinical trial, said Dr Cherian in an interaction with newsmen here today.

The BPV has the advantages that not only it is durable, but also anti coagulation drugs are not required  which has to be given in case of replacement of a damaged  cardiac valve with a mechanical one. 

He said that the BPV developed by USA costs around Rs 73,000 per valve which is not affordable by poor patients and if the indigenous one is cleared it would cost round Rs 30,000. It is being developed on a metal frame over which a  bovine (Buffalo , pig) tissue is attached.

On an average 4 million people in the country are requirement of heart valve .  The valve and tissue business in the world is expected to be around 8.5  to 12 billion US dollars by 20202, said Dr Cherian.  If India could contribute atleast 1 percent of the demand by BPV , it would save the lives  of not only Indians, but also people in SAARC and African countries  , said Dr Cherian.

Stay up to date on all the latest Tamil Nadu news with The New Indian Express App. Download now

Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp